However, molecular methods, such as microarrays, have strong limitations when analyzing MYCN amplification and other genetic changes in neuroblastoma because molecular methods are based on DNA from a mixture of cells and therefore only provide an average result for a particular tumor. Here, MYCN is linked to neuroblastoma.